InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,018.00
(
1.58%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.51
(
1.27%
)
Bitcoin
66,435.16
(
-0.63%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Snackman

Send PM Follow Ignore
Followers 99
Posts 8760
Boards Moderated 0
Alias Born 07/21/2003

Snackman

Member Level

Re: None

Saturday, 05/13/2017 1:41:57 AM

Saturday, May 13, 2017 1:41:57 AM

Post# of 4273
Buying picks up in Synergy after Ardelyx's tenapanor data; shares ahead 11%

May 12, 2017 1:14 PM ET|About: Synergy Pharmaceutical... (SGYP)|By: Douglas W. House, SA News Editor

Money flow has turned positive in Synergy Pharmaceuticals (SGYP +10.8%) albeit on modestly higher volume. Earlier today, would-be competitor Ardelyx (ARDX -36.7%) announced positive late-stage data on IBS-C candidate tenapanor but with a 14.6% rate of diarrhea, higher that Trulance's 5% (data from studies in chronic ideopathic constipation).

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up